{
    "clinical_study": {
        "@rank": "151170", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This multi-center, non-drug study will explore the relationship between exploratory\n      biomarkers and functional dimensions in male adult individuals with Autistic Disorder or\n      Asperger's Syndrome and healthy volunteer controls. Subjects will undergo a number of\n      assessments on study visit Day 1."
        }, 
        "brief_title": "A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Volunteer, Autistic Disorder, Asperger's Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Autistic Disorder", 
                "Asperger Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Individuals with Autistic Disorder or Asperger's Syndrome:\n\n          -  Male adults, 18 to 45 years of age inclusive\n\n          -  Diagnosis of Autistic Disorder or Asperger's Syndrome as defined by DSM-IV\n\n          -  IQ >70\n\n          -  Body mass index (BMI) 18 to 35 kg/m2\n\n          -  Availability of a reliable caregiver, able and willing to provide information\n             regarding the individual's behavior and symptoms\n\n        Healthy controls:\n\n          -  Healthy male adults, 18 to 45 years of age inclusive\n\n          -  IQ >70\n\n          -  Body mass index (BMI) 18 to 30 kg/m2\n\n        Exclusion Criteria:\n\n        General exclusion criteria:\n\n          -  Positive test for drugs of abuse or alcohol\n\n          -  Confirmed systolic blood pressure >140 or <90 mmHg, and diastolic blood pressure >90\n             or <50 mmHg\n\n          -  Resting pulse rate >100 or <40 beats per minute\n\n          -  Alcohol and/or substance abuse/dependence during the last 12 months\n\n          -  Concomitant disease or condition that could interfere with, or treatment of which\n             might interfere with, the conduct of the study, or that would, in the opinion of the\n             investigator, pose an unacceptable risk to the subject in this study\n\n        Additionally for individuals with Autistic Disorder or Asperger's Syndrome:\n\n          -  History of epilepsy/seizure disorder (except simple febrile seizures)\n\n               -  Significant disruptive, aggressive or self-injurious, or sexually inappropriate\n                  behavior during the last 3 months that in the opinion of the investigator might\n                  interfere with the conduct of the study\n\n        Additionally for healthy controls:\n\n          -  Clinically significant abnormalities in laboratory test results\n\n          -  History of or current psychiatric, neurological disorder or pervasive developmental\n             disorder"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "High functioning (IQ >70) male adult individuals with Autistic Disorder or Asperger's\n        Syndrome and  age and IQ matched healthy male volunteers"
            }
        }, 
        "enrollment": {
            "#text": "23", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669889", 
            "org_study_id": "BP28421"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Ageles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06510"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Behavior assessment ratings", 
                "safety_issue": "No", 
                "time_frame": "approximately 5 months"
            }, 
            {
                "measure": "Cognition assessment ratings", 
                "safety_issue": "No", 
                "time_frame": "approximately 5 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669889"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}